Showing results (41-50 of 186) with videos related to
Sort By:
Pageof 19
Bioorganic & Medicinal Chemistry|February 5, 2004
Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agentsSimon M Jones, Jonathan E Urch, Reto Brun, et al.Plos One|June 1, 2019
Identification of inhibitors of an unconventional Trypanosoma brucei kinetochore kinaseLeah S Torrie, Fabio Zuccotto, David A Robinson, et al.Nature Communications|April 27, 2026
FMOPhore for hotspot identification and efficient fragment-to-lead growth strategiesPeter E G F Ibrahim, Simone Altmann, Ulrich Zachariae, et al.Drug Discovery Today|November 8, 2016
Fragment library design, synthesis and expansion: nurturing a synthesis and training platformPeter C Ray, Michael Kiczun, Margaret Huggett, et al.Nucleic Acids Research|April 22, 2021
Mycobacterium tuberculosis Phe-tRNA synthetase: structural insights into tRNA recognition and aminoacylationKarolina Michalska, Robert Jedrzejczak, Jacek Wower, et al.Organic & Biomolecular Chemistry|February 13, 2014
Probing the substrate specificity of Trypanosoma brucei GlcNAc-PI de-N-acetylase with synthetic substrate analoguesAmy S Capes, Arthur Crossman, Michael D Urbaniak, et al.Bioorganic & Medicinal Chemistry|March 10, 2005
Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductaseSoghra Khabnadideh, Didier Pez, Alexander Musso, et al.Journal of Virology|July 27, 2007
Mechanistic insights into the cure of prion disease by novel antiprion compoundsSarah Webb, Tamuna Lekishvili, Corinna Loeschner, et al.European Journal of Medicinal Chemistry|September 7, 2010
Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylaseHuaqing Cui, Gian Filippo Ruda, Juana Carrero-Lérida, et al.Pageof 19